Literature DB >> 21906787

Does the Pulmonary Embolism Severity Index accurately identify low risk patients eligible for outpatient treatment?

Petra M G Erkens1, Esteban Gandara, Philip S Wells, Alex Yi-Hao Shen, Gauruv Bose, Gregoire Le Gal, Marc Rodger, Martin H Prins, Marc Carrier.   

Abstract

INTRODUCTION: The pulmonary embolism severity index (PESI) and the recently derived simplified PESI prognostic model have been developed to estimate the risk of 30-day mortality in patients with acute PE. We sought to assess if the PESI and simplified PESI prognostic models can accurately identify adverse events and to determine the rates of events in patients treated as outpatients.
METHODS: A retrospective cohort study of patients with acute pulmonary embolism (PE) presenting at the Ottawa Hospital (Canada) was conducted between 1 January 2007 and 31 December 2008.
RESULTS: Two hundred and forty three patients were included. A total of 118 (48.6%) and 81 (33.3%) were classified as low risk patients using the original and simplified PESI prognostic models respectively. None of the low risk patients died within the 3months of follow-up. One hundred and fifteen (47.3%) patients were safely treated as outpatients with no deaths or bleeding episodes and only 1 recurrent event within the first 14days or after 30days of follow-up. Thirty four (29.6%) of these outpatients were classified as high risk patients according to the original PESI and 54 (47.0%) to the simplified PESI prognostic model.
CONCLUSION: Both PESI strategies accurately identify patients with acute PE who are at low risk and high risk for short-term adverse events. However, 30 to 47% of patients with acute PE and a high risk PESI score were safely managed as outpatients. Future research should be directed at developing tools that predict which patients would benefit from inpatient management.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21906787     DOI: 10.1016/j.thromres.2011.08.025

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  10 in total

1.  Prognostic value of D-dimer in elderly patients with Pulmonary Embolism.

Authors:  Hernan Polo Friz; Chiara Buzzini; Annalisa Orenti; Veronica Punzi; Mauro Molteni; Laura Primitz; Luca Cavalieri d'Oro; Guido Arpaia; Patrizia Boracchi; Claudio Cimminiello
Journal:  J Thromb Thrombolysis       Date:  2016-10       Impact factor: 2.300

Review 2.  Multidetector computed tomography pulmonary angiography in childhood acute pulmonary embolism.

Authors:  Chun Xiang Tang; U Joseph Schoepf; Shahryar M Chowdhury; Mary A Fox; Long Jiang Zhang; Guang Ming Lu
Journal:  Pediatr Radiol       Date:  2015-04-07

3.  A new prognostic strategy for adult patients with acute pulmonary embolism eligible for outpatient therapy.

Authors:  Federico Angriman; Fernando J Vazquez; Pierre Marie Roy; Gregoire Le Gal; Marc Carrier; Esteban Gandara
Journal:  J Thromb Thrombolysis       Date:  2017-04       Impact factor: 2.300

4.  Comorbidity assessment as predictor of short and long-term mortality in elderly patients with hemodynamically stable acute pulmonary embolism.

Authors:  Hernan Polo Friz; Valeria Corno; Annalisa Orenti; Chiara Buzzini; Chiara Crivellari; Francesco Petri; Melisa Polo Friz; Veronica Punzi; Daniela Teruzzi; Luca Cavalieri d'Oro; Cristina Giannattasio; Giuseppe Vighi; Claudio Cimminiello; Patrizia Boracchi
Journal:  J Thromb Thrombolysis       Date:  2017-10       Impact factor: 2.300

5.  Treatment of pulmonary embolism with rivaroxaban: outcomes by simplified Pulmonary Embolism Severity Index score from a post hoc analysis of the EINSTEIN PE study.

Authors:  Gregory J Fermann; Petra M G Erkens; Martin H Prins; Philip S Wells; Ákos F Pap; Anthonie W A Lensing
Journal:  Acad Emerg Med       Date:  2015-02-25       Impact factor: 3.451

6.  Use of prestudy heparin did not influence the efficacy and safety of rivaroxaban in patients treated for symptomatic venous thromboem-bolism in the EINSTEIN DVT and EINSTEIN PE studies.

Authors:  Paolo Prandoni; Martin H Prins; Alexander T Cohen; Katharina Müller; Ákos F Pap; Miriam C Tewes; Anthonie W A Lensing
Journal:  Acad Emerg Med       Date:  2015-02-09       Impact factor: 3.451

7.  Emergency Department Patient Satisfaction with Treatment of Low-risk Pulmonary Embolism.

Authors:  Laura E Simon; Hilary R Iskin; Ridhima Vemula; Jie Huang; Adina S Rauchwerger; Mary E Reed; Dustin W Ballard; David R Vinson
Journal:  West J Emerg Med       Date:  2018-10-18

8.  Hyponatremia and 30 days mortality of patients with acute pulmonary embolism.

Authors:  Babak Tamizifar; Saeid Kheiry; Farid Fereidoony
Journal:  J Res Med Sci       Date:  2015-08       Impact factor: 1.852

Review 9.  Prognostic models in acute pulmonary embolism: a systematic review and meta-analysis.

Authors:  Antoine Elias; Susan Mallett; Marie Daoud-Elias; Jean-Noël Poggi; Mike Clarke
Journal:  BMJ Open       Date:  2016-04-29       Impact factor: 2.692

10.  Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study.

Authors:  Andria Medina; Gary Raskob; Walter Ageno; Alexander T Cohen; Marjolein P A Brekelmans; Cathy Z Chen; Michael A Grosso; Michele F Mercuri; Annelise Segers; Peter Verhamme; Thomas Vanassche; Philip S Wells; Min Lin; Shannon M Winters; Jeffrey I Weitz; Harry R Büller
Journal:  Thromb Haemost       Date:  2017-12-06       Impact factor: 5.249

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.